Trial Profile
Immunological effect of early extra MMR immunization in infants between 6 and 12 months of age in an outbreak setting Immunologisch effect van een vroege extra BMR vaccinatie in zuigelingen tussen 6 en 12 maanden oud tijdens een uitbraak
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 02 Oct 2013
Price :
$35
*
At a glance
- Drugs Measles mumps and rubella virus vaccine (Primary) ; Meningococcal vaccine group C conjugate (Primary)
- Indications Measles; Meningococcal group C infections; Mumps; Rubella
- Focus Pharmacodynamics
- 02 Oct 2013 New trial record